Intrinsic Value Partners’s Bristol-Myers Squibb BMY Stock Holding History

Intrinsic Value Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,507	Closed	-$204K	–	54
2023 Q3	$204K	Sell	3,507 -1,249	-26%	-$76.5K	0.26%	51
2023 Q2	$304K	Sell	4,756 -390	-8%	-$26.2K	0.38%	48
2023 Q1	$357K	Sell	5,146 -40	-0.8%	-$2.82K	0.48%	42
2022 Q4	$373K	Sell	5,186 -2,230	-30%	-$168K	0.51%	42
2022 Q3	$527K	Sell	7,416 -2,730	-27%	-$198K	0.73%	34
2022 Q2	$781K	Sell	10,146 -1,202	-11%	-$91.5K	1%	24
2022 Q1	$829K	Sell	11,348 -232	-2%	-$15.6K	0.88%	25
2021 Q4	$722K	Buy	+11,580	New	+$679K	0.77%	27

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Intrinsic Value Partners's BMY Position: Q4 2023 in Review

Intrinsic Value Partners sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 3,507 shares — an estimated $204K sold.

Intrinsic Value Partners first reported a position in BMY in Q4 2021 and held it in 8 quarters. The position peaked at $829K in Q1 2022. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Intrinsic Value Partners reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Intrinsic Value Partners sold 3,507 Bristol-Myers Squibb shares in Q4 2023, an estimated $204K.
Intrinsic Value Partners first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 8 quarters.
Intrinsic Value Partners's Bristol-Myers Squibb position peaked at $829K in Q1 2022.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Intrinsic Value Partners's 13F filing for Q4 2023, filed 7 Feb 2024.